When was Ikotech founded?

Ikotech was founded in 2005 and raised its 1st funding round 4 years after it was founded.

Where is Ikotech located?

Ikotech is headquartered in New Albany, United States.

Is Ikotech a funded company?

Ikotech is a funded company, having raised a total of $275K across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on May 04, 2009.

When was the latest funding round of Ikotech?

Ikotech's latest funding was a $***** Seed round on Jun 06, 2011, with participation from 0 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $407M in funding in 2026 to date.

Where does Ikotech rank among its competitors?

Ikotech ranks 57th amongst 54 active competitors, of which 16 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Cytomos, which secured $6.32M in Nov, 2024.

Who are the top competitors of Ikotech?

Ikotech's top competitors include ThinkCyte, Silicon Biosystems and NanoCellect Biomedical. Among them, Cytomos secured the most recent funding round in November, 2024.

Ikotech - 2026 Company Profile, Funding & Competitors

Company Details

Tech support elevating construction with IT solutions and drone services. They offer comprehensive technology support, from office to field, specializing in construction technology adoption and integration. Services include software support for platforms like PROCORE, Bluebeam, and AutoDesk, alongside hardware assistance. They enhance project efficiency with FAA-certified drone operations, providing aerial imagery, 3D mapping, and site inspections. Customized IT solutions are built to advance businesses, offering flexible support plans, including remote and on-site options. They align systems and workflows to simplify operations, boost efficiency, and support long-term growth. Co-Managed IT support is available, partnering with in-house IT teams. Their approach is people-driven, focusing on understanding business needs and delivering solutions that empower teams. They implement market-leading technologies with a personal touch, emphasizing that IT is about people.

Website: www.ikotech.com/
Social
Email ID: *****@ikotech.com

Key Metrics

Founded Year

2005

Location

New Albany, United States

Stage

Deadpooled

Total Funding

$275K in 2 rounds

Latest Funding Round

Seed, Jun 06, 2011, $*****

Ranked

57^th among 65 competitors

Similar Companies

ThinkCyte & 63 more

View Ikotech's full profile

Ikotech has raised a total funding of $275K over 2 rounds. Its first funding round was on May 04, 2009.

Here is the list of recent funding rounds of Ikotech:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 06, 2011	8921575	Seed	6440102	1646962	6190875	6950748
May 04, 2009	6857673	Seed	7703784	9769240	7550350	1812820

Access funding benchmarks and valuations. Sign up today!

View details of Ikotech's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Ikotech include ThinkCyte, Silicon Biosystems and NanoCellect Biomedical. Here is the list of Top 10 competitors of Ikotech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	ThinkCyte 2016, Bunkyo (Japan), Series C	Developer of cell sorting and single cell profiling platforms	$83.2M	SPARX Group, ITV & 19 others	62/100
2nd	Silicon Biosystems 1999, Bologna (Italy), Acquired	Developer of lab on a chip technologies for miniaturized cell-biology testing	$25.5M	Innogest Capital, IMI Fondi Chiusi SGR & 1 others	57/100
3rd	NanoCellect Biomedical 2009, San Diego (United States), Series D	Develops flow cytometry and cell sorting technology	$78.1M	Warburg Pincus, Illumina Ventures & 15 others	55/100
4th	Singulex 1997, Alameda (United States), Series G	Revolutionizing immunodiagnostics with ultra-sensitive technology to transform healthcare	$141M	Orbimed, JAFCO Group & 10 others	51/100
5th	Cellular Highways 2016, Melbourn (United Kingdom), Acquired	Developer of cell sorting device	-	-	50/100
6th	nanoMR 2006, Albuquerque (United States), Acquired	Developed the system for rapid isolation of rare cells	$25.5M	Dow Chemical Company, Excel Venture Management ... & 4 others	49/100
7th	Cytena 2014, Freiburg im Breisgau (Germany), Acquired	Single cell isolation technology	$4.59M	HTGF	48/100
8th	Cytomos 2012, Edinburgh (United Kingdom), Series A	POC cell sorter	$13.6M	Archangels, Scottish Enterprise & 21 others	48/100
9th	Immunicon 1983, Bryn Athyn (United States), Acquired	Cell and molecular-based human diagnostic and life science research products for cancer disease management	$75.3M	Flare Capital Partners, Wheatley Partners ... & 10 others	44/100
10th	Cell Microsystems 2009, Durham (United States), Series B	Developer of a technology to isolate and recover single cells for molecular analysis	$19.1M	Telegraph Hill Partners, Telegraph Hill Partners ... & 4 others	43/100
57th	Ikotech 2005, New Albany (United States), Deadpooled	Tech support elevating construction with IT solutions and drone services	$275K	-	18/100